An analysis of the clinico-pathological findings in 49 patients with adenocarcinoma of unknown primary origin indicates a short survival time. No factors were identified that influenced survival. Thromboembolic episodes and second primary tumors commonly complicate the clinical course. Metastases in
โฆ LIBER โฆ
Acups (adenocarcinoma of unknown primary site): A clinical and cost benefit analysis
โ Scribed by C.S. Hamilton; A.O. Langlands
- Book ID
- 103722372
- Publisher
- Elsevier Science
- Year
- 1987
- Tongue
- English
- Weight
- 849 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Adenocarcinoma of unknown primary site:
โ
Snyder, R. D. ;Mavligit, G. M. ;Valdivieso, M.
๐
Article
๐
1979
๐
John Wiley and Sons
๐
English
โ 326 KB
Adenocarcinoma of unknown primary site.
โ
W. Edward Jordan III; Richard A. Shildt
๐
Article
๐
1985
๐
John Wiley and Sons
๐
English
โ 444 KB
Metastatic adenocarcinoma of unknown pri
โ
Hedley, David W.; Leary, Jennifer A.; Kirsten, Fred
๐
Article
๐
1985
๐
Elsevier Science
โ 488 KB
Metastatic adenocarcinoma of unknown pri
โ
Markman, Maurie
๐
Article
๐
1982
๐
John Wiley and Sons
๐
English
โ 286 KB
## Abstract A retrospective review of 245 patients with metastatic adenocarcinomas of unknown primary site (ACUP) seen at The Johns Hopkins Hospital from 1965โ1979 was undertaken. The median survival was 3.1 months. Age, sex, race, and year of diagnosis did not appear to influence survival. Patient
Cancers of unknown primary site: ESMO Cl
โ
Fizazi, K.; Greco, F. A.; Pavlidis, N.; Pentheroudakis, G.
๐
Article
๐
2011
๐
Oxford University Press
๐
English
โ 137 KB
Cost Benefit Analysis of Topical Tranexa
โ
Tuttle, John R.; Ritterman, Scott A.; Cassidy, Dale B.; Anazonwu, Walter A.; Fro
๐
Article
๐
2014
๐
Elsevier Science
๐
English
โ 196 KB